
Fampyra (fampridine) is indicated for use in multiple sclerosis to improve walking in patients who have a walking disability (EDSS 4-7).
Pharmacology
Fampridine is a potassium channel blocker. It prolongs channel repolarisation which enhances action potential formation in demyelinated axons, leading to improved neurological function.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1310